Gambaran Umum
Dynavax Technologies Corporation, based in the United States, primarily operates within the biopharmaceutical industry. The company is focused on leveraging the power of the body's innate and adaptive immune responses through its proprietary toll-like receptor (TLR) stimulation technology. One of its notable products is HEPLISAV-B, a hepatitis B vaccine that offers enhanced immunogenicity and convenience with a two-dose regimen, compared to the typical three-dose schedule of other available vaccines. Dynavax also actively collaborates on various projects aimed at developing vaccines for infectious diseases, including a collaboration on a COVID-19 vaccine. These projects illustrate Dynavax's strategic emphasis on innovation and partnerships to expand its vaccine technology applications.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Dynavax Technologies Corporation per 2025 Jun 30 adalah 316.27 MM.
- Nilai operating income untuk Dynavax Technologies Corporation per 2025 Jun 30 adalah 8.11 MM.
- Nilai net income untuk Dynavax Technologies Corporation per 2025 Jun 30 adalah -52.73 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 316.27 | 8.11 | -52.73 |
2025-03-31 | 294.62 | -1.14 | -60.07 |
2024-12-31 | 277.25 | 0.89 | 27.31 |
2024-09-30 | 260.81 | -6.18 | 20.48 |
2024-06-30 | 249.69 | -12.36 | 17.18 |
2024-03-31 | 236.15 | -21.17 | 9.22 |
2023-12-31 | 232.28 | -30.45 | -6.39 |
2023-09-30 | 361.18 | 86.61 | 61.12 |
2023-06-30 | 459.40 | 143.92 | 110.64 |
2023-03-31 | 655.62 | 274.58 | 235.97 |
2022-12-31 | 722.68 | 290.21 | 293.16 |
2022-09-30 | 733.26 | 310.37 | 325.20 |
2022-06-30 | 673.80 | 264.04 | 232.96 |
2022-03-31 | 470.10 | 145.63 | 108.68 |
2021-12-31 | 439.44 | 141.22 | 76.71 |
2021-09-30 | 257.62 | 42.22 | -38.53 |
2021-06-30 | 162.77 | 6.38 | -5.70 |
2021-03-31 | 112.67 | -25.88 | -61.75 |
2020-12-31 | 40.25 | -73.82 | -75.24 |
2020-09-30 | 37.57 | -82.57 | -96.53 |
Laporan Laba Rugi: EPS
- earnings per share basic untuk Dynavax Technologies Corporation pada 2025 Jun 30 adalah -0.42.
- laba per saham yang terdilusi untuk Dynavax Technologies Corporation pada 2025 Jun 30 adalah -0.42.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | -0.42 | -0.42 |
2025-03-31 | -0.47 | -0.47 |
2024-12-31 | 0.21 | 0.20 |
2024-09-30 | 0.16 | 0.16 |
2024-06-30 | 0.13 | 0.13 |
2024-03-31 | 0.07 | 0.07 |
2023-12-31 | -0.05 | -0.05 |
2023-09-30 | 0.48 | 0.47 |
2023-06-30 | 0.87 | 0.81 |
2023-03-31 | 1.85 | 1.65 |
2022-12-31 | 2.32 | 1.97 |
2022-09-30 | 2.57 | 2.04 |
2022-06-30 | 1.87 | 1.55 |
2022-03-31 | 0.87 | 0.75 |
2021-12-31 | 0.62 | 0.57 |
2021-09-30 | -0.34 | -0.34 |
2021-06-30 | -0.05 | -0.10 |
2021-03-31 | -0.58 | -0.53 |
2020-12-31 | -0.75 | -0.78 |
2020-09-30 | -1.02 | -1.07 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Dynavax Technologies Corporation per 2025 Jun 30 adalah 76.27 MM.
- Nilai cash from investing activities untuk Dynavax Technologies Corporation per 2025 Jun 30 adalah 109.60 MM.
- Nilai kas dari aktivitas pendanaan untuk Dynavax Technologies Corporation per 2025 Jun 30 adalah -200.20 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | 76.27 | 109.60 | -200.20 |
2025-03-31 | 63.55 | -13.96 | -129.70 |
2024-12-31 | 66.51 | -18.04 | -102.02 |
2024-09-30 | 27.27 | -61.64 | -1.37 |
2024-06-30 | 38.93 | -152.25 | -0.85 |
2024-03-31 | 56.26 | -98.76 | 0.27 |
2023-12-31 | 100.56 | -153.93 | 1.39 |
2023-09-30 | 121.75 | -166.65 | -0.24 |
2023-06-30 | 152.18 | -179.63 | 4.83 |
2023-03-31 | 140.78 | -151.85 | 6.15 |
2022-12-31 | 62.72 | -316.00 | 19.52 |
2022-09-30 | 148.26 | -228.09 | 34.19 |
2022-06-30 | 152.92 | -63.37 | 31.45 |
2022-03-31 | 247.05 | -179.62 | 33.76 |
2021-12-31 | 335.53 | 14.22 | 55.78 |
2021-09-30 | 199.29 | -26.37 | 41.03 |
2021-06-30 | 105.26 | -74.10 | 37.12 |
2021-03-31 | -27.35 | -59.73 | 127.26 |
2020-12-31 | -92.25 | -26.53 | 109.50 |
2020-09-30 | -99.52 | -16.02 | 109.43 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk Dynavax Technologies Corporation pada 2025 Jun 30 adalah 2.31.
- p/tbv untuk Dynavax Technologies Corporation pada 2025 Jun 30 adalah 2.31.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 2.31 | 2.31 | |
2025-03-31 | 2.84 | ||
2024-12-31 | 2.48 | 2.48 | |
2024-09-30 | 83.92 | 2.24 | 2.25 |
2024-06-30 | 161.38 | 2.41 | 2.41 |
2024-03-31 | 2.61 | 2.61 | |
2023-12-31 | 29.55 | 2.99 | 3.00 |
2023-09-30 | 17.18 | 3.29 | 3.31 |
2023-06-30 | 7.13 | 2.98 | 2.99 |
2023-03-31 | 4.27 | 2.16 | |
2022-12-31 | 4.17 | 2.71 | 2.72 |
2022-09-30 | 3.12 | 3.14 | |
2022-06-30 | 5.53 | 5.57 | |
2022-03-31 | 17.68 | 6.10 | 6.16 |
2021-12-31 | -43.80 | 24.98 | 25.80 |
2021-09-30 | -386.63 | 26.44 | 27.16 |
2021-06-30 | |||
2021-03-31 | -17.66 | 10.93 | 11.18 |
2020-12-31 | -13.94 | 17.87 | 18.60 |
2020-09-30 | -10.87 | 15.14 | 15.63 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Dynavax Technologies Corporation pada 2025 Jun 30 adalah -0.06.
- EBIT (3 tahun) / EV untuk Dynavax Technologies Corporation pada 2025 Jun 30 adalah 0.03.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.06 | 0.03 |
2025-03-31 | 0.02 | 0.05 |
2024-12-31 | 0.02 | 0.08 |
2024-09-30 | 0.02 | 0.13 |
2024-06-30 | 0.01 | 0.11 |
2024-03-31 | -0.00 | 0.07 |
2023-12-31 | 0.04 | 0.08 |
2023-09-30 | 0.06 | 0.06 |
2023-06-30 | 0.14 | 0.09 |
2023-03-31 | 0.33 | 0.13 |
2022-12-31 | 0.24 | 0.05 |
2022-09-30 | 0.18 | 0.03 |
2022-06-30 | 0.07 | -0.01 |
2022-03-31 | 0.07 | -0.03 |
2021-12-31 | -0.02 | -0.05 |
2021-09-30 | -0.00 | -0.04 |
2021-06-30 | ||
2021-03-31 | -0.05 | -0.10 |
2020-12-31 | -0.06 | -0.11 |
2020-09-30 | -0.08 | -0.11 |
Efektivitas Manajemen
- roa untuk Dynavax Technologies Corporation pada 2025 Jun 30 adalah -0.06.
- roe untuk Dynavax Technologies Corporation pada 2025 Jun 30 adalah -0.09.
- roic untuk Dynavax Technologies Corporation pada 2025 Jun 30 adalah -0.07.
- croic untuk Dynavax Technologies Corporation pada 2025 Jun 30 adalah -0.09.
- ocroic untuk Dynavax Technologies Corporation pada 2025 Jun 30 adalah 0.07.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.06 | -0.09 | -0.07 | -0.09 | 0.07 |
2025-03-31 | 0.03 | 0.04 | 0.03 | -0.06 | 0.08 |
2024-12-31 | 0.02 | 0.03 | 0.02 | -0.03 | 0.03 |
2024-09-30 | 0.02 | 0.03 | 0.02 | -0.12 | 0.04 |
2024-06-30 | 0.01 | 0.02 | 0.01 | -0.04 | 0.06 |
2024-03-31 | -0.01 | -0.01 | -0.01 | -0.06 | 0.11 |
2023-12-31 | 0.06 | 0.12 | 0.06 | -0.05 | 0.13 |
2023-09-30 | 0.11 | 0.26 | 0.13 | -0.03 | 0.18 |
2023-06-30 | 0.23 | 0.56 | 0.13 | -0.03 | 0.18 |
2023-03-31 | 0.29 | 1.02 | 0.28 | -0.01 | 0.16 |
2022-12-31 | 0.35 | 4.81 | 0.43 | -0.06 | 0.20 |
2022-09-30 | 0.25 | 3.45 | 0.43 | -0.06 | 0.20 |
2022-06-30 | 0.17 | 1.30 | 0.34 | 0.18 | 0.22 |
2022-03-31 | 0.16 | 0.77 | 0.20 | 0.18 | 0.45 |
2021-12-31 | -0.11 | -0.66 | 0.16 | 0.84 | 0.61 |
2021-09-30 | -0.11 | -0.08 | -0.12 | 0.66 | 0.31 |
2021-06-30 | -0.02 | -0.10 | -0.02 | 0.20 | 0.31 |
2021-03-31 | -0.24 | -5.22 | -0.19 | 0.13 | -0.09 |
2020-12-31 | -0.27 | -9.08 | -0.27 | -0.03 | -0.33 |
2020-09-30 | -0.32 | -2.47 | -0.30 | -0.02 | -0.31 |
Gross Margins
- marjin kotor untuk Dynavax Technologies Corporation pada 2025 Jun 30 adalah 0.61.
- marjin bersih untuk Dynavax Technologies Corporation pada 2025 Jun 30 adalah -0.20.
- marjin operasi untuk Dynavax Technologies Corporation pada 2025 Jun 30 adalah -0.00.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.61 | -0.20 | -0.00 |
2025-03-31 | 0.61 | 0.10 | 0.00 |
2024-12-31 | 0.63 | 0.08 | -0.02 |
2024-09-30 | 0.50 | 0.07 | -0.05 |
2024-06-30 | 0.53 | 0.04 | -0.09 |
2024-03-31 | 0.56 | -0.03 | -0.13 |
2023-12-31 | 0.62 | 0.17 | 0.21 |
2023-09-30 | 0.60 | 0.24 | 0.29 |
2023-06-30 | 0.62 | 0.24 | 0.29 |
2023-03-31 | 0.62 | 0.36 | 0.40 |
2022-12-31 | 0.59 | 0.44 | 0.42 |
2022-09-30 | 0.56 | 0.44 | 0.42 |
2022-06-30 | 0.53 | 0.35 | 0.39 |
2022-03-31 | 0.54 | 0.23 | 0.31 |
2021-12-31 | 0.49 | 0.18 | 0.33 |
2021-09-30 | 0.52 | -0.15 | 0.18 |
2021-06-30 | 0.52 | -0.03 | 0.07 |
2021-03-31 | 0.45 | -0.55 | -0.23 |
2020-12-31 | -1.87 | -1.83 | |
2020-09-30 | -0.09 | -2.57 | -2.20 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1029142 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |